v3.25.2
Share-Based Payments - Share-Based Compensation Expense Included In Statements Of Income (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Share-based Compensation Expense included in consolidated statements of income        
Subtotal $ 78.1 $ 72.9 $ 162.2 $ 144.3
Capitalized share-based compensation costs (3.2) (2.3) (6.3) (5.6)
Share-based compensation expense included in total cost and expense 74.9 70.6 155.9 138.7
Income tax effect (14.9) (13.4) (30.9) (26.3)
Research and development        
Share-based Compensation Expense included in consolidated statements of income        
Share-based compensation expense 30.1 27.3 62.2 54.7
Selling, general and administrative        
Share-based Compensation Expense included in consolidated statements of income        
Share-based compensation expense 48.0 45.6 100.0 89.6
Share-based compensation expense included in net income attributable to Biogen Inc.        
Share-based Compensation Expense included in consolidated statements of income        
Share-based compensation expense $ 60.0 $ 57.2 $ 125.0 $ 112.4